VI.2.2 Summary of treatment benefit 99m Tc-Pertechnetate is the most important diagnostic agent today

Share "VI.2.2 Summary of treatment benefit 99m Tc-Pertechnetate is the most important diagnostic agent today"

N/A

Protected

Ano acadêmico: 2023

Info

Descarregar agora

Protected

Academic year: 2023

Share "VI.2.2 Summary of treatment benefit 99m Tc-Pertechnetate is the most important diagnostic agent today"

Copied!

Carregando.... (Ver texto completo agora)

Descarregar agora ( 4 páginas )

Texto

Referências

Descarregar agora ( PDF - 4 páginas - 25.02 KB )

Documentos relacionados

Summary EU-Risk Management Plan NL/H/3508/01-03/MR

Summary EU-Risk Management Plan NL/H/3508/01-03/MR - Spironolactone Accord Risk What is known Preventability Spironolactone Accord” Common: too much potassium in the blood

Documentos relacionados

VI.2 ELEMENTS FOR A PUBLIC SUMMARY VI.2.1 Overview of Disease Epidemiology

•The UK population has one of the highest average serum cholesterol levels in the world

PUBLIC SUMMARY OF RISK MANAGEMENT PLAN DATE

Summary EU-Risk Management Plan SE/H/1589/001+004-005

7.1.2 Part VI.2.2 Summary of treatment benefits

VI.2.2 Summary of treatment benefits

VI.2 Elements for a Public Summary

Lenalidomide Basics 2.5 mg, 5 mg, 7.5 mg 10 mg, 15 mg, 20 mg and 25 mg hard capsules